Molecular Imaging Biomarkers for Oncology Clinical Trials

被引:55
|
作者
Mankoff, David A. [1 ]
Pryma, Daniel A. [1 ]
Clark, Amy S. [2 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
关键词
cancer biomarkers; clinical trials; cancer therapy; BREAST-CANCER; FDG-PET; TRASTUZUMAB; CRITERIA;
D O I
10.2967/jnumed.113.126128
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This "Focus on Molecular Imaging" article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging.
引用
收藏
页码:525 / 528
页数:4
相关论文
共 50 条
  • [31] Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?
    Berger, Frank
    Reiser, Maximilian F.
    THERANOSTICS, 2013, 3 (12): : 932 - 941
  • [32] Using virtual clinical trials to determine the accuracy of AI-based quantitative imaging biomarkers in oncology trials using standard-of-care CT
    Byrd, Darrin
    Bontempi, Dennis
    Yang, Hao
    Aerts, Hugo
    Zhao, Binsheng
    Fedorov, Andriy
    Schwartz, Lawrence
    Allison, Tavis
    Moscowitz, Chaya
    Kinahan, Paul
    MEDICAL IMAGING 2022: IMAGE PERCEPTION, OBSERVER PERFORMANCE, AND TECHNOLOGY ASSESSMENT, 2022, 12035
  • [33] Imaging Biomarkers in Radiation Oncology and Beyond: Development, Evaluation and Clinical Translation
    Waterton, J.
    Tyagi, N.
    Yamamoto, T.
    El Naqa, I.
    MEDICAL PHYSICS, 2020, 47 (06) : E310 - E310
  • [34] Multiple biomarkers in molecular oncology
    Johann, Donald J., Jr.
    Veenstra, Timothy D.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (03) : 223 - 225
  • [35] Clinical Trials and the Role of the Oncology Clinical Trials Nurse
    Ness, Elizabeth A.
    Royce, Cheryl
    NURSING CLINICS OF NORTH AMERICA, 2017, 52 (01) : 133 - +
  • [36] WIDEN: A tool for medical imaging management in oncology clinical trials.
    Chauvie, Stephane
    Biggi, Alberto
    Stancu, Alexandru
    Cerello, Piergiorgio
    Gallamini, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] The Importance of Imaging in Radiation Oncology for National Clinical Trials Network Protocols
    FitzGerald, Thomas J.
    Bishop-Jodoin, Maryann
    Laurie, Fran
    O'Meara, Elizabeth
    Davis, Christine
    Bogart, Jeffrey
    Kalapurakal, John
    Siegel, Marilyn J.
    Chakravarthy, Bapsi
    Okunieff, Paul
    Haffty, Bruce
    Michalski, Jeff
    Ulin, Kenneth
    Followill, David S.
    Kry, Stephen
    Knopp, Michael
    Zhang, Jun
    Rosen, Don
    Rosen, Mark
    Xiao, Ying
    Schwartz, Lawrence
    Moni, Janaki
    Cicchetti, Maria Giulia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (04): : 775 - 782
  • [38] Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future
    Aupperle-Lellbach, Heike
    Kehl, Alexandra
    de Brot, Simone
    van der Weyden, Louise
    VETERINARY SCIENCES, 2024, 11 (05)
  • [39] Regulatory Issues in use of Biomarkers in Oncology Trials
    Chakravarty, Aloka G.
    Rothmann, Mark
    Sridhara, Rajeshwari
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2011, 3 (04): : 569 - 576
  • [40] ClinicalOmicsDB: exploring molecular associations of oncology drug responses in clinical trials
    Moon, Chang In
    Elizarraras, John Michael
    Lei, Jonathan Thomas
    Jia, Byron
    Zhang, Bing
    NUCLEIC ACIDS RESEARCH, 2024, 52 (D1) : D1201 - D1209